Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Palfreyman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1974
Potential chemotherapeutic agents. Formation of 2,7-naphthyridones from nicotinamide derivativesM N Palfreyman, K R Wooldridge
Progress in Medicinal Chemistry|January 1, 1996
Phosphodiesterase type IV inhibitorsM N Palfreyman, J E Souness
Prostaglandins|May 1, 1984
Uterine stimulant action of some 16-phenoxy analogues of (+)-11-deoxyprostaglandin E1M P Caton, E C Coffee, D J Hambling, et al.
Journal of Medicinal Chemistry|May 28, 1993
Syntheses and biological activities of potent potassium channel openers derived from (+/-)-2-oxo-1-pyridin-3-yl-cyclohexanecarbothioic acid methylamide: new potassium channel openersT J Brown, R F Chapman, J S Mason, et al.
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
A structural analog of thromboxane A2M F Ansell, M P Caton, M N Palfreyman, et al.
British Journal of Pharmacology|June 1, 1996
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformerJ E Souness, M Griffin, C Maslen, et al.
British Journal of Pharmacology|May 1, 1995
Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipramJ E Souness, C Maslen, S Webber, et al.
Prostaglandins|April 1, 1980
Synthesis and antifertility activity of omega-chain phenyl- and 16-phenoxy-analogues of (+/-)-11-deoxyprostaglandin F1 alphaB J Broughton, M P Caton, E C Coffee, et al.
Journal of Medicinal Chemistry|May 27, 1994
Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analoguesM J Ashton, D C Cook, G Fenton, et al.
Journal of Medicinal Chemistry|October 2, 1992
Synthesis and biological activity of trans(+-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogues: a new class of potassium channel openerT J Brown, R F Chapman, D C Cook, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1974
Potential chemotherapeutic agents. Formation of 2,7-naphthyridones from nicotinamide derivativesM N Palfreyman, K R Wooldridge
Progress in Medicinal Chemistry|January 1, 1996
Phosphodiesterase type IV inhibitorsM N Palfreyman, J E Souness
Prostaglandins|May 1, 1984
Uterine stimulant action of some 16-phenoxy analogues of (+)-11-deoxyprostaglandin E1M P Caton, E C Coffee, D J Hambling, et al.
Journal of Medicinal Chemistry|May 28, 1993
Syntheses and biological activities of potent potassium channel openers derived from (+/-)-2-oxo-1-pyridin-3-yl-cyclohexanecarbothioic acid methylamide: new potassium channel openersT J Brown, R F Chapman, J S Mason, et al.
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
A structural analog of thromboxane A2M F Ansell, M P Caton, M N Palfreyman, et al.
British Journal of Pharmacology|June 1, 1996
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformerJ E Souness, M Griffin, C Maslen, et al.
British Journal of Pharmacology|May 1, 1995
Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipramJ E Souness, C Maslen, S Webber, et al.
Prostaglandins|April 1, 1980
Synthesis and antifertility activity of omega-chain phenyl- and 16-phenoxy-analogues of (+/-)-11-deoxyprostaglandin F1 alphaB J Broughton, M P Caton, E C Coffee, et al.
Journal of Medicinal Chemistry|May 27, 1994
Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analoguesM J Ashton, D C Cook, G Fenton, et al.
Journal of Medicinal Chemistry|October 2, 1992
Synthesis and biological activity of trans(+-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogues: a new class of potassium channel openerT J Brown, R F Chapman, D C Cook, et al.
Pageof 2